The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDairy Crest Regulatory News (DCG)

  • There is currently no data for DCG

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Interim Management Statement

9 Feb 2017 07:00

RNS Number : 3784W
Dairy Crest Group PLC
09 February 2017
 

 

9 February 2017

 

Dairy Crest Group plc ("Dairy Crest")

 

Interim Management Statement

 

Dairy Crest is today issuing its Interim Management Statement for the nine months ended 31 December 2016.

 

Outlook

 

The outlook for the full year remains in line with our expectations.

 

Branded performance

 

Our key brands have continued to perform well. Clover, Frylight and Country Life have all grown volumes in the first nine months of the year and have taken significant share in their respective markets. As predicted, Cathedral City performance improved in the third quarter.

 

Overall, in the first nine months of the year the combined volumes of Cathedral City, Country Life, Clover and Frylight are in line with the same period last year.

 

Innovation and brand building continues to be at the heart of what we do. Clover and Frylight have both seen new packaging launches during the quarter and Frylight has been supported by a new TV advertising campaign over the last six weeks. In January 2017, Clover won the spreads category "Product of the Year 2017" award in the world's largest consumer survey award for product innovation. This is a testimony to the work we undertook to remove artificial ingredients from Clover. Furthermore, in October 2016 Frylight won the Institute of Grocery and Distribution Health and Wellness award. We will continue to invest in innovation and marketing across our key brands through 2017.

 

Functional Ingredients

 

Production of demineralised whey powder and galacto-oligosaccharide ("GOS"), both ingredients for the growing global infant formula market, continues to develop well at our factory in Davidstow. There have been significant improvements in the percentage level of demineralised whey hitting the important infant formula grade. We remain confident that this will continue to rise and that we will hit our target of over 80% by 31 March 2017.

 

On 21 December 2016, Dairy Crest announced that it had entered into a research partnership with Danisco Animal Nutrition, part of DuPont, to further explore the potential uses of GOS in poultry and swine. If successful, this work would help to broaden the potential market for GOS beyond infant formula.

 

Balance sheet

 

We have seen further milk cost inflation since the half year and have now announced increases in the price paid to farmers of 8.28 pence per litre since June 2016. This represents an increase of 38%. Furthermore, market prices for cream have remained high after more than doubling in the first half of the year. The cream price determines the input costs for our butter business. These movements inevitably result in a short-term working capital outflow and, as a result, we now expect year end net debt to be somewhat higher than 31 March 2016.

 

New auditor appointment

 

The Board has approved the appointment of Deloitte as external auditor for the year commencing 1 April 2017. This appointment will be subject to shareholder approval at the 2017 Annual General Meeting. The Group's current auditor, Ernst & Young, is retiring by rotation and will carry out the audit for the year ending 31 March 2017. The Board would like to thank Ernst & Young for their contribution to the business over many years.

 

 

 

Mark Allen, Chief Executive of Dairy Crest, commented:

 

"The outlook for the full year remains in line with our expectations.

 

The business has continued to make progress during the quarter. Our brands have performed well supported by successful innovation and brand investment. I'm particularly pleased to see the improvement in Cathedral City's performance.

 

At the new Davidstow functional ingredients facility we are seeing significant improvement in the percentage level of demineralised whey meeting infant formula grade. This is important in maximising future opportunities in this market.

 

The announcement of the partnership with Danisco Animal Nutrition marks a further significant step in the development of GOS beyond infant formula. This has exciting potential opportunities for the future."

 

 

Dairy Crest will issue its Preliminary Results for the year ending 31 March 2017 on 18 May 2017.

 

 

 

For further information, please contact:

Dairy Crest

Alistair Smith

01372 472236

Dairy Crest

Tom Atherton

01372 472264

Brunswick

Mike Smith

0207 404 5959

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCQVLFBDLFBBBX
Date   Source Headline
18th Nov 201610:02 amRNSTR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
10th Nov 20167:00 amRNSInterim Results
31st Oct 201612:23 pmRNSTotal Voting Rights & Capital
30th Sep 201610:17 amRNSTotal Voting Rights
19th Sep 20167:00 amRNSTrading Statement
31st Aug 20169:53 amRNSTotal Voting Rights & Capital
12th Aug 20165:22 pmRNSDirector/PDMR Shareholding
1st Aug 201611:40 amRNSTotal Voting Rights
21st Jul 20164:01 pmRNSDirector/PDMR Shareholding
21st Jul 20164:00 pmRNSDirector/PDMR Shareholding
20th Jul 20162:45 pmRNSDirector/PDMR Shareholding
20th Jul 20169:23 amRNSResults of AGM held on 19 July 2016
19th Jul 20164:59 pmRNSBoard Appointment
19th Jul 20163:59 pmRNSNon-executive Director Notification
19th Jul 20167:00 amRNSAGM and Interim Management Statement
8th Jul 20163:07 pmRNSDirector/PDMR Shareholding
30th Jun 201611:05 amRNSTotal Voting Rights
24th Jun 20162:58 pmRNSDirector/PDMR Shareholding
20th Jun 20167:00 amRNS2016 Annual Report and Accounts and Notice of AGM
3rd Jun 20163:11 pmRNSDirector/PDMR Shareholding
2nd Jun 201612:10 pmRNSBlock listing Interim Review
31st May 20169:51 amRNSTotal Voting Rights
19th May 20167:00 amRNSPreliminary Results
3rd May 201611:10 amRNSTotal Voting Rights & Capital
1st Apr 201612:08 pmRNSTotal Voting Rights
1st Mar 20164:12 pmRNSDirector/PDMR Shareholding
1st Mar 20162:44 pmRNSTotal Voting Rights & Capital
26th Feb 20162:12 pmRNSBlocklisting Interim Review
11th Feb 20167:00 amRNSInterim Management Statement
1st Feb 20165:01 pmRNSDirector/PDMR Shareholding
29th Jan 201610:51 amRNSTotal Voting Rights
8th Jan 20163:54 pmRNSDirector/PDMR Shareholding
6th Jan 20169:47 amRNSTotal Voting Rights
29th Dec 20157:00 amRNSCompletion of sale of Dairies operations
21st Dec 20157:00 amRNSOwnership of Galacto-Oligosaccharide business
1st Dec 201510:58 amRNSTotal Voting Rights
17th Nov 201511:25 amRNSBlocklisting Interim Review
16th Nov 20153:28 pmRNSDirector/PDMR Shareholding
13th Nov 201512:06 pmRNSAdditional Listing
5th Nov 20157:00 amRNSInterim Results
30th Oct 201512:15 pmRNSTotal Voting Rights
29th Oct 20153:08 pmRNSHolding(s) in Company
22nd Oct 20153:37 pmRNSHolding(s) in Company
19th Oct 20153:17 pmRNSSale of Dairies will complete in December 2015
19th Oct 20159:30 amRNSHolding(s) in Company
15th Oct 201510:42 amRNSHolding(s) in Company
30th Sep 20152:52 pmRNSSale of Dairy Crest's Dairies operations
30th Sep 201510:42 amRNSTotal Voting Rights
22nd Sep 20157:00 amRNSTrading Statement
1st Sep 20159:40 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.